Moreover, cancer cells can develop mechanisms for preventing immune cells from infiltrating the tumor microenvironment (TME) despite adequate immunogenicity [93], such as by secreting immunosuppressive chemokines, by the induction of the loss of MHC antigen expression, and by recruiting higher number of immunosuppresive cells in the TME [94]. The gene discussed is HLA-C; the disease is neoplasm.